Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB4754770,11
PKN37,837,98-2,28
Msft-1,10
Nokia2,89152,90652,75
IBM2,53
Daimler AG44,59544,6150,40
PFE0,57
31.10.2020 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 30.10.2020 17:36:24
m-u-t AG (M7UG.DE, Xetra)
Závěr k 30.10.2020 Změna (%) Změna (EUR) Objem obchodů (EUR)
29,80 3,83 1,10 149 434
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 31.10.2020
Popis společnosti
Obecné informace
Název společnostiNynomic AG
TickerM7U
Kmenové akcie:Ordinary Shares
RICM7UG.DE
ISINDE000A0MSN11
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky30.09.2020
Počet zaměstnanců k 30.06.2020 431
Akcie v oběhu k 30.06.2020 5 323 500
MěnaEUR
Kontaktní informace
UliceAm Marienhof 2
MěstoWEDEL
PSČ22880
ZeměGermany
Kontatní osobaJochen Fischer
Funkce kontaktní osobyInvestor Relations Contact Officer
Telefon49 410 393 080
Fax494103930899
Kontatní telefon4940 822 186 380

Business Summary: Nynomic AG, formerly mut AG, is a Germany-based company engaged in the provision of photonics, optical technology and microelectronics solutions. It covers product conception, design, evaluation, development and market introduction, and operates through three segments: Clean Tech, Green Tech and Life Science. The Clean Tech segment offers sensors and measuring systems for industrial producers and system operates, such as bioplants; the Green Tech segment focuses on farming solutions, as well as the food and beverage industries, and offers solutions for harvest monitoring and animal feeding, and the Life Science segment focuses on medical technology, such as spectrometers, laboratory instruments and other analytical solutions.
Financial Summary: BRIEF: For the six months ended 30 June 2020, Nynomic AGrevenues increased 26% to EUR36.9M. Net income decreased19% to EUR2.2M. Revenues reflect Clean Tech segmentincrease of 34% to EUR23.6M, Life Science segment increaseof 24% to EUR8.1M, United States segment increase of 48% toEUR10.5M, Germany,EU and other countries segment increaseof 16% to EUR23.3M. Net income was offset by Wages andSalaries increase of 21% to EUR14.1M (expense).
Odvětvová klasifikace
TRBC2009Office Equipment
TRBC2012Scientific & Precision Equipment
RBSS2004Electrical Components & Equipment
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Optical Instrument & Lens Mfg
NAICS2007Industrial Process Control Mfg
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Optical Instrument and Lens Manufacturing
NAICS1997Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
SICAnalytical Instruments
SICOptical Instruments And Lenses
SICProcess Control Instruments



  • Poslední aktualizace: 31.10.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory BoardHans Woermcke56
Member of the Management BoardMaik Mueller-01.05.201501.05.2015
Member of the Management BoardFabian Peters-01.01.201501.01.2015
Vice Chairman of the Supervisory BoardHartmut Harbeck-01.01.201401.01.2014